DS

Dipali Shrutin Ulman

Active Director Director DIN 10802416
DIN 10802416 First appointment Oct 2024
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value •••• Premium profile

About Dipali Shrutin Ulman

Data last updated:

Dipali Shrutin Ulman is a Director at Ulman Clinical Private Limited (since 2024). Ulman Clinical Private Limited reported revenue of ₹18.2 Lakh (FY 2025).

DIN 10802416
Primary Designation Director
First Appointment 08 Oct 2024
Oldest Company Age 2 yrs
Largest company Ulman Clinical Private Limited · ₹18.2 Lakh (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Ulman Clinical Private Limited U46596KA2024PTC193779
Director08 Oct 20242024₹18.2 Lakh (FY 2025)Active

Board colleagues of Dipali Shrutin Ulman

NameDINCompanyDesignation
Shrutin Ashok Ulman10802415Ulman Clinical Private LimitedDirector

Directorship timeline

Open interactive timeline →
Ulman Clinical Private Limited
Premium access

Shareholding and investment profile for Dipali Shrutin Ulman

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Dipali Shrutin Ulman

Dipali Shrutin Ulman currently holds 1 directorship: Ulman Clinical Private Limited (Director, since 08 Oct 2024, revenue ₹18.2 Lakh (FY 2025)).

Dipali Shrutin Ulman was first appointed on 08 Oct 2024 as Director at Ulman Clinical Private Limited.

The current boards of Dipali Shrutin Ulman's companies include Shrutin Ashok Ulman (Ulman Clinical Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available